BACKGROUND: The development and validation of Norfolk QOL-DN, a fiber-specific, quality-of-life tool for diabetic neuropathy, was published previously (Part 1). This study (Part 2) defines the psychometric properties of the German-translated Norfolk QOL-DN in a large multicenter (96 sites) population with neuropathy ranging from minimal to severe, comparing them with those in the original English/American version in a 30-center European/North American population with mild neuropathy; determines the power of the German-translated version in a five-staged diabetic peripheral neuropathy (DPN) German population to discriminate different levels of neuropathy severity; and establishes factors having the greatest impact on QOL. METHODS: One hundred eighty-six German patients were assessed: asymptomatic of DPN (n = 40), symptomatic (n = 46), DN with foot-ulcer history (n = 32), DN with amputations (n = 22), and DN amputation history (n = 46). German-translated Norfolk QOL-DN was administered to 177 patients with staged DN complications. German-translated Norfolk QOL-DN data were compared with QOL-DN data from the European/American study of 379 mild neuropathy patients. Exploratory factor analysis assessed factor structure consistency in the translated instrument. Ordinal regression analysis (polytomous universal model) was used to evaluate the association between factor scores and complication stages. RESULTS: The German translation identified the same five factors in more advanced neuropathy as in the English mild neuropathy population. Total QOL scores differed among each of the five neuropathy severity groups [analysis of variance p < 0.001, Tukey-Kramer post hoc, alpha = 0.05]. Two factors emerged as predictors of impaired QOL and disease severity: physical function/large fiber (Wald chi(2) = 6.188, p = 0.013) and activities of daily living (ADL)(Wald chi(2) = 9.098, p = 0.003). CONCLUSIONS: Norfolk QOL-DN discriminates levels of neuropathy within and between populations. Physical functioning and ADL are the most important determinants of QOL. Early occurrence of orthostasis suggests a redefinition of autonomic neuropathy to be more symptom inclusive.
BACKGROUND: The development and validation of Norfolk QOL-DN, a fiber-specific, quality-of-life tool for diabetic neuropathy, was published previously (Part 1). This study (Part 2) defines the psychometric properties of the German-translated Norfolk QOL-DN in a large multicenter (96 sites) population with neuropathy ranging from minimal to severe, comparing them with those in the original English/American version in a 30-center European/North American population with mild neuropathy; determines the power of the German-translated version in a five-staged diabetic peripheral neuropathy (DPN) German population to discriminate different levels of neuropathy severity; and establishes factors having the greatest impact on QOL. METHODS: One hundred eighty-six German patients were assessed: asymptomatic of DPN (n = 40), symptomatic (n = 46), DN with foot-ulcer history (n = 32), DN with amputations (n = 22), and DN amputation history (n = 46). German-translated Norfolk QOL-DN was administered to 177 patients with staged DN complications. German-translated Norfolk QOL-DN data were compared with QOL-DN data from the European/American study of 379 mild neuropathypatients. Exploratory factor analysis assessed factor structure consistency in the translated instrument. Ordinal regression analysis (polytomous universal model) was used to evaluate the association between factor scores and complication stages. RESULTS: The German translation identified the same five factors in more advanced neuropathy as in the English mild neuropathy population. Total QOL scores differed among each of the five neuropathy severity groups [analysis of variance p < 0.001, Tukey-Kramer post hoc, alpha = 0.05]. Two factors emerged as predictors of impaired QOL and disease severity: physical function/large fiber (Wald chi(2) = 6.188, p = 0.013) and activities of daily living (ADL)(Wald chi(2) = 9.098, p = 0.003). CONCLUSIONS: Norfolk QOL-DN discriminates levels of neuropathy within and between populations. Physical functioning and ADL are the most important determinants of QOL. Early occurrence of orthostasis suggests a redefinition of autonomic neuropathy to be more symptom inclusive.
Entities:
Keywords:
ADLs; QOL; autonomic; large fiber; nerve fiber specific
Authors: Andrew J M Boulton; Arthur I Vinik; Joseph C Arezzo; Vera Bril; Eva L Feldman; Roy Freeman; Rayaz A Malik; Raelene E Maser; Jay M Sosenko; Dan Ziegler Journal: Diabetes Care Date: 2005-04 Impact factor: 19.112
Authors: Loretta Vileikyte; Howard Leventhal; Jeffrey S Gonzalez; Mark Peyrot; Richard R Rubin; Jan S Ulbrecht; Adam Garrow; Christine Waterman; Peter R Cavanagh; Andrew J M Boulton Journal: Diabetes Care Date: 2005-10 Impact factor: 19.112
Authors: Phillip A Low; Lisa M Benrud-Larson; David M Sletten; Tonette L Opfer-Gehrking; Stephen D Weigand; Peter C O'Brien; Guillermo A Suarez; Peter J Dyck Journal: Diabetes Care Date: 2004-12 Impact factor: 19.112
Authors: Eugene J Barrett; Zhenqi Liu; Mogher Khamaisi; George L King; Ronald Klein; Barbara E K Klein; Timothy M Hughes; Suzanne Craft; Barry I Freedman; Donald W Bowden; Aaron I Vinik; Carolina M Casellini Journal: J Clin Endocrinol Metab Date: 2017-12-01 Impact factor: 5.958
Authors: Jennifer S Gewandter; Laurie Burke; Guido Cavaletti; Robert H Dworkin; Christopher Gibbons; Tony D Gover; David N Herrmann; Justin C Mcarthur; Michael P McDermott; Bob A Rappaport; Bryce B Reeve; James W Russell; A Gordon Smith; Shannon M Smith; Dennis C Turk; Aaron I Vinik; Roy Freeman Journal: Muscle Nerve Date: 2016-12-23 Impact factor: 3.217
Authors: Cosmina I Bondor; Ioan A Veresiu; Bogdan Florea; Etta J Vinik; Aaron I Vinik; Norina A Gavan Journal: J Diabetes Res Date: 2016-02-25 Impact factor: 4.011
Authors: Norina A Gavan; Ioan A Veresiu; Etta J Vinik; Aaron I Vinik; Bogdan Florea; Cosmina I Bondor Journal: J Diabetes Res Date: 2016-11-29 Impact factor: 4.011
Authors: Jennifer J Brown; Shana L Pribesh; Kimberly G Baskette; Aaron I Vinik; Sheri R Colberg Journal: J Diabetes Res Date: 2017-11-08 Impact factor: 4.011